TNF α(Q34)Mouse Monoclonal Antibody

TNF α(Q34)Mouse Monoclonal Antibody

Size1:50μl Price1:$118
Size2:100μl Price2:$220
Size3:500μl Price3:$980
SKU: AMM19084 Category: Mouse Monoclonal Antibody Tags: , , , ,

Datasheet

Summary

Production Name

TNF α(Q34)Mouse Monoclonal Antibody

Description

Mouse Monoclonal Antibody

Host

Mouse

Application

WB,IHC,IF

Reactivity

Human,Rat,Mouse

 

Performance

Conjugation

Unconjugated

Modification

Unmodified

Isotype

IgG

Clonality

Monoclonal

Form

Liquid

Storage

Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.

Buffer

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% New type preservative N.

Purification

Affinity purification

 

Immunogen

Gene Name

TNF TNFA TNFSF2

Alternative Names

Tumor necrosis factor (Cachectin;TNF-alpha;Tumor necrosis factor ligand superfamily member 2;TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment;NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]

Gene ID

7124

SwissProt ID

P01375

 

Application

Dilution Ratio

WB 1:1000-1:3000 IHC 1:50-1:200. IF 1:50-200

Molecular Weight

17,25kD

 

Background

This gene encodes a multifunctional proinflammatory cytokine that belongs to the tumor necrosis factor (TNF) superfamily. This cytokine is mainly secreted by macrophages. It can bind to, and thus functions through its receptors TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. This cytokine is involved in the regulation of a wide spectrum of biological processes including cell proliferation, differentiation, apoptosis, lipid metabolism, and coagulation. This cytokine has been implicated in a variety of diseases, including autoimmune diseases, insulin resistance, and cancer. Knockout studies in mice also suggested the neuroprotective function of this cytokine. [provided by RefSeq, Jul 2008],disease:Cachexia accompanies a variety of diseases, including cancer and infection, and is characterized by general ill health and malnutrition.,disease:Genetic variations in TNF are associated with susceptibility to hepatitis B virus infection (HBV infection) [MIM:610424]. Approximately one third of all cases of cirrhosis and half of all cases of hepatocellular carcinoma can be attributed to chronic HBV infection. HBV infection may result in subclinical or asymptomatic infection, acute self-limited hepatitis, or fulminant hepatitis requiring liver transplantation.,disease:Genetic variations in TNF are associated with susceptibility to psoriatic arthritis [MIM:607507]. Psoriasis is a chronic inflammatory dermatosis that affects approximately 2% of the population. It is characterized by red, scaly skin lesions that are usually found on the scalp, elbows, and knees, and may be associated with severe arthritis. Psoriatic arthritis has been defined as an inflammatory arthritis usually without any rheumatoid factor in serum (seronegative arthritis) associated with psoriasis.,function:Cytokine that binds to TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. It is mainly secreted by macrophages and can induce cell death of certain tumor cell lines. It is potent pyrogen causing fever by direct action or by stimulation of interleukin-1 secretion and is implicated in the induction of cachexia, Under certain conditions it can stimulate cell proliferation and induce cell differentiation.,online information:The Singapore human mutation and polymorphism database,online information:Tumor necrosis factor alpha entry,PTM:O-glycosylated; glycans contain galactose, N-acetylgalactosamine and N-acetylneuraminic acid.,PTM:The membrane form, but not the soluble form, is phosphorylated on serine residues. Dephosphorylation of the membrane form occurs by binding to soluble TNFRSF1A/TNFR1.,PTM:The soluble form derives from the membrane form by proteolytic processing.,similarity:Belongs to the tumor necrosis factor family.,subunit:Homotrimer.,

 

Research Area

MAPK_ERK_Growth;MAPK_G_Protein;Cytokine-cytokine receptor interaction;Apoptosis_Inhibition;Apoptosis_Mitochondrial;Apoptosis_Overview;TGF-beta;Toll_Like;NOD-like receptor;RIG-I-like receptor;Hematopoietic cell lineage;Natural killer cell mediated cytotoxicity;T_Cell_Receptor;Fc epsilon RI;Adipocytokine;Type II diabetes mellitus;Type I diabetes mellitus;Alzheimer's disease;Amyotrophic lateral sclerosis (ALS);Asthma;Systemic lupus erythematosus;Allograft rejection;Graft-versus-host disease;Hypertrophic cardiomyopathy (HCM);Dilated cardiomyopathy;